GOVERNANCE
Efficiency and multidisciplinarity: The
foundations of the MammoScreen project.
The multidisciplinary structure of MammoScreen is based on flexibility and an efficient management, for an optimal organisation and collaboration among the involved parties.
To achieve the project expected outcomes we devised a governance structure which guarantees an effective implementation of the tasks and a successful engagement of all stakeholders.
The main bodies of the project
General Assembly
The General Assembly is composed of one representative from each MammoScreen partner organisation, and it is the highest decision-making body of the project. It will decide on all major and strategic issues addressed during the project, which will substantially affect the scope, direction and content of the project.
COORDINATOR
Fondazione Toscana Life Sciences
Short name:
TLS
Country:
Italy
Gianni D’Errico
Dr. Letizia Pontoriero
Dr. Matteo Gentili
PARTNER
Umbria Bioengineering Technologies S.r.l.
Short name:
UBT
Country:
Italy
Sabatino Tiberi
Dr. Gianluigi Tiberi
Dr. Navid Gavhami
Dr. Banafsheh Khalesi
Alessandra Bigotti
Gianmarco Palomba
Mario Badia
PARTNER
Servicio de Salud de Castilla La Mancha
Short name:
SESCAM
Country:
Spain
Daniel Álvarez Sánchez-Bayuela
Cristina Romero
Aarón Darío Martínez Gómez
PARTNER
Scuola IMT (Istituzioni, Mercati, Tecnologie) Alti Studi di Lucca
Short name:
IMT
Country:
Italy
Prof. Massimo Riccaboni
Prof. Giorgio Stefano Gnecco
Anisie Uwimane
Ennio Bilancini
PARTNER
ASSOCIAÇÃO EVITA - CANCRO HEREDITÁRIO
Short name:
EVITA
Country:
Portugal
Tamara Milagre
Vanessa Ferreira
Tatiana Vassilevskaia
Mariana Coutinho
Laura Carreto
PARTNER
ELAROS 24/7 LIMITED
Short name:
ELAROS
Country:
United Kingdom
Prof. Paul O’Brien
Henry Robinson
Jennifer McDonald
Oscar Petherick
Román Rocha Lawrence
James McMunn
Prof Jennie Wilson
Toby Boud
PARTNER
London South Bank University LBG
Short name:
LSBU
Country:
United Kingdom
Mohammad Ghavami
Mehran Taghipour-Gorjikolaie
Dr. Bilal Khalid
Data and Ethic Advisory Board
The Data and Ethics Advisory Board has been established to provide advice on the ethical conduction of clinical research in humans and the corresponding data use. The board is an independent, consultant body for the ethical issues of the projects and will report to the executive board.
Dr. Nicola Stingelin-Giles
Dr. Emanuele Crocetti
Scientific Advisory Board
The Scientific Advisory Board (SAB) is composed of external experts with outstanding scientific and/or industrial background and will support the General Assembly in key decisions, providing guidance on scientific, ethical and policy-related aspects while the ultimate decision body is the General Assembly.
More specifically, the SAB is expected to provide guidance on the following topics:
Patient Association
Regulatory aspects
Release of documents, rationales, reports and papers
Other technical/scientific issues
The Scientific Advisory Board is composed of the following experts:
Dr. Fatima Cardoso
Prof. Walter van Dyck
Prof. Massimo Calabrese
Prof. Alberto Tagliafico
Patient Advisory Group
The Patient Advisory Group (PAG) is an external board gathering the representatives of the major national/European patient organizations that will be invited to support MammoScreen and provide guidance on the following topics:
- Clinical protocol
- Development of patients’ continuous engagement tools
- Dissemination and communication strategy
The PAG is chaired by Siobhan Freeney, an internationally recognized and highly enthusiastic patient advocate.
Siobhan Freeny
Knowledge Management Board
The Knowledge Management Board will assess all the outcomes of the project and will advise the partners on the most adequate IP protection strategy. The board will also provide support to all the partners when engaging with third parties for the collaboration to happen in full respect of each other’s IP background and also with a clear understandings about the foreground likely to be produced. The Board, which is participated by one representative per each partner, oversees the following activities:
- Pre-review of each scientific article prior to the journal submission in order to assess that no interest of any party is jeopardised;
- Facilitate the IPR management according to the rules established in the Consortium Agreement;
- Facilitate the dissemination of the project within the scientific community;
- Facilitate the interaction with the project stakeholders;
- Facilitate the public engagement for a wider adoption of MammoWave approach throughout Europe;
- Business amplification: to liaise and support each partner on Business strategy, Business intelligence and any other business-related aspects.
Within MammoScreen TLS clinical Research Team has been involved from the very outset and is providing guidance on:
TLS has also involved its Clinical Study Team with the goal to support all the partners, the Data and Ethics Advisory Board (EAB), the Scientific Advisory Board (SAB) and Clinical Research Organization (CRO) in the proper implementation of the clinical study. The Clinical Research Team has been established by TLS with the goal to overview the clinical development of TLS multiple research and innovation projects carried out to tackle big health challenges such as cancer, infectious diseases as well as rare and orphan diseases. Within MammoScreen TLS clinical Research Team has been involved from the very outset and is providing guidance on:
- Identification and selection of the most appropriate CRO;
- Identifying the Clinical Centers;
- Definition of the clinical protocol and all the related documents for the proper management of the study;
- Engagement of the Ethical Committees and review of the documents requested for the assessment and approval of the clinical study,
- Proper collection and storage of all the study related documentation, in compliance with Good Clinical Practice (GCP) standards;
- Overall monitoring of the study;
Identification and selection of the most appropriate CRO
Identifying the Clinical Centers
Definition of the clinical protocol and all the related documents for the proper management of the study
Engagement of the Ethical Committees and review of the documents requested for the assessment and approval of the clinical study
Proper collection and storage of all the study related documentation, in compliance with Good Clinical Practice (GCP) standards
Overall monitoring of the study
The team has a very interdisciplinary expertise which encompass regulatory aspects, ethical aspects and intellectual property, privacy and data protection.
The team has a very interdisciplinary expertise which encompass regulatory aspects, ethical aspect and intellectual property, privacy and data protection.
Find out the latest news about MammoScreen world and stay up to date with the project.
Join our Community
The team has a very interdisciplinary expertise which encompass regulatory aspects, ethical aspect and intellectual property, privacy and data protection.
Find out the latest news about MammoScreen world and stay up to date with the project.
